Efficacy and Safety of NestaCell® in Huntington's Disease

Clinical trial NCT06097780 · UNKNOWN

Trial details

NCT number: NCT06097780
Sponsor: Azidus Brasil
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Huntington Disease

Start date: 2024-06-08
Primary completion: 2025-09-08
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.